ADORA2A and familial pancreatic carcinoma: Of the four receptors, Adora2a and Adora2b have been reported as high in PDAC and are overexpressed in the pancreas during pancreatic cancer; yet only high expression of Adora2b receptor was shown to correlate with significantly reduced survival in PDAC patients.